“It is a completely reasonable precautionary measure,” assures the chairman of the advisory board of the vaccine strategy on franceinfo.
Posted
Update
Reading time : 1 min.
The High Authority for Health recalls that “the two RNA vaccines that are the vaccines developed by the companies Pfizer and Moderna are extraordinarily effective”, assures, Monday, November 8 on franceinfo, the professor Alain Fischer, president of the council of orientation of the vaccine strategy. The HAS has announced that it is now advising against vaccinations against Covid-19 with Moderna’s vaccine for those under 30, due to a possible increased risk of myocarditis in the youngest.
“There really is nothing to worry about, it is a very reasonable precautionary measure in the face of two globally effective and safe vaccines.”, recalls Alain Fischer.
The Pfizer vaccine like the Moderna vaccine “have a benefit / risk ratio which remains excellent. There is still a choice, and in the state of knowledge, cases of myocarditis are a little less frequent with the Pfizer vaccine in people under 30 years old. put in the safest situation. For those under 30, it is better to do with the Pfizer “, explains Alain Fisher.